(250mg) Gefitinib "'

Gefitinib (250mg)
GEFISTERIS is a medication that falls under the category of tyrosine kinase inhibitors (TKIs). GEFISTERIS is used in the treatment of non-small cell lung cancer (NSCLC), specifically for cases where the cancer cells have specific mutations in the epidermal growth factor receptor (EGFR) gene. EGFR mutations are more common in certain subsets of NSCLC patients, and drugs like gefitinib target these mutated receptors.
GEFISTERIS works by inhibiting the activity of the EGFR tyrosine kinase, which is involved in the signaling pathways that promote cell growth, division, and survival. By blocking this activity, GEFISTERIS helps slow down or stop the growth of cancer cells with EGFR mutations.
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
info@sterispharma.com
order now:
https://www.sterisonline.com/product/gefisteris-250-133658